ACHV · Achieve Life Sciences, Inc. · Executive Compensation
$7.11
+0.10 (+1.43%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$771.77M
Shares
102.90M
Volume · Oct 5
1.7M
Avg daily vol (3M)
1.47M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Richard Stewart | Former Chief Executive Officer | $1,368,525 |
| Erik Atkisson | Chief Legal Officer | $983,403 |
| Jaime Xinos | Former Chief Commercial Officer | $944,601 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John Bencich | Former Chief Executive Officer | $2,518,977 |
| Richard Stewart | Chief Executive Officer | $1,735,552 |
| Cindy Jacobs | President and Chief Medical Officer | $1,281,518 |
| Jaime Xinos | Former Chief Commercial Officer | $1,056,470 |
| Mark Oki | Chief Financial Officer | $1,015,388 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John Bencich | Former Chief Executive Officer | $1,697,957 |
| Richard Stewart | Chief Executive Officer | $1,350,905 |
| Cindy Jacobs | President and Chief Medical Officer | $1,202,464 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John Bencich | Chief Executive Officer | $1,504,795 |
| Richard Stewart | Executive Chairman | $1,269,503 |
| Cindy Jacobs | President and Chief Medical Officer | $1,115,835 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John Bencich | Chief Executive Officer | $1,611,883 |
| Richard Stewart | Executive Chairman | $1,331,135 |
| Cindy Jacobs | President and Chief Medical Officer | $1,058,391 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Richard Stewart | Executive Chairman | $1,032,505 |
| John Bencich | Chief Executive Officer | $883,732 |
| Cindy Jacobs | President and Chief Medical Officer | $773,902 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Richard Stewart | Executive Chairman | $796,644 |
| Anthony Clarke | President and Chief Scientific Officer | $589,657 |
| Cindy Jacobs | President and Chief Medical Officer | $580,857 |
| John Bencich | Chief Executive Officer | $570,547 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Richard Stewart | Executive Chairman and Former Chief Executive Officer | $1,090,265 |
| Anthony Clarke | President and Chief Scientific Officer | $721,927 |
| Cindy Jacobs | President and Chief Medical Officer | $712,207 |
| John Bencich | Chief Executive Officer and Former Chief Financial Officer and Chief Operating Officer | $694,714 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Cindy Jacobs | Executive Vice President and Chief Medical Officer | $1,146,298 |
| John Bencich | Executive Vice President and Chief Financial Officer and Chief Operating Officer | $1,143,901 |
| Richard Stewart | Chairman and Chief Executive Officer | $208,333 |
| Anthony Clarke | President and Chief Scientific Officer | $175,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Benjamin Halladay | Chief Financial Officer and "principal financial officer" | Appointed | 2026-10-01 |
| Reid Waldman, M.D. | director | Appointed | 2026-06-02 |
| Jeff Farrow | director | Appointed | 2026-06-02 |
| Thomas King | member and as chairman of the Board | Resigned | 2026-05-12 |
| Lucian Iancovici | Chair of the Board | Appointed | 2026-05-12 |
| Christopher Martin | director | Appointed | 2026-05-12 |
| Andrew D. Goldberg | member of the board of directors | Appointed | 2026-04-16 |
| Andrew D. Goldberg | Chief Executive Officer | Appointed | 2026-04-16 |
| Aaron Royston | director | Appointed | 2026-04-16 |
| Andrew Goldberg | director | Appointed | 2026-04-16 |
| Lucian Iancovici | director | Appointed | 2026-04-16 |
| Andrew Goldberg | Chief Executive Officer | Appointed | 2026-04-16 |
| Dr. Cindy Jacobs | Chief Medical Officer and President | Resigned | 2025-10-07 |
| Dr. Cindy Jacobs | Chief Medical Officer and President | Resigned | 2025-09-11 |
| Nancy R. Phelan | director of the Company | Appointed | 2025-01-10 |
| Kristen B. Slaoui | director of the Company | Appointed | 2025-01-10 |
| Vaughn Himes | member of the Board | Resigned | 2025-01-10 |
| Mark K. Oki | Chief Financial Officer and “principal financial officer” | Appointed | 2024-12-09 |
| Thomas B. King | Executive Chairman | Appointed | 2024-08-26 |
| Richard Stewart | Chief Executive Officer | Appointed | 2024-08-26 |
| Richard Stewart | Executive Chairman | Resigned | 2024-08-26 |
| John Bencich | director | Resigned | 2024-08-26 |
| Thomas Sellig | director | Appointed | 2023-03-30 |
| Thomas King | director | Appointed | 2023-03-30 |
| Stuart Duty | director | Appointed | 2023-03-30 |